Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer

By Naya Y.   Fritsche H.A.   Cheli C.D.   Stamey T.A.   Bartsch G.   Brawer M.K.   Childs S.   Taneja S.S.   Lepor H.   Partin A.W.   Sokoll L.J.   Chan D.W.   Babaian R.J.  

Urology, Vol. 62, Iss. 6, 2003-12 ,pp. : 1058-1062

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?

By Carroll P.R.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 591-593

Elsevier

Access to resources Recommend Favorite

Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection

By Taneja S.S.   Tran K.   Lepor H.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer

By Stephan C.   Jung K.   Diamandis E.P.   Rittenhouse H.G.   Lein M.   Loening S.A.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 2-8

Elsevier

Access to resources Recommend Favorite

The Role of the Complexed-to-Total Prostate-Specific Antigen Ratio in Predicting the Final Pathological Stage of Clinically Localized Prostate Cancer

By Martnez M.   Navarro S.   Medina P.   Villavicencio H.   Rioja L.   Solsona E.   Estelles A.   Aznar J.   Jimenez-Cruz J.F.   Espana F.  

European Urology, Vol. 43, Iss. 6, 2003-06 ,pp. : 609-614

Elsevier

Access to resources Recommend Favorite